Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 02 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release announcing that it received final approval from the USFDA for Acyclovir Cream. The cream is used to treat cold sores caused by the herpes simplex virus and will soon be launched in the US market. The product will be manufactured at Zydus's facility in Ahmedabad, India.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases